A phase II study of exemestane (Aromasin) with or without celecoxib for the treatment of postmenopausal women with estrogen reception positive metastatic breast cancer
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2005
At a glance
- Drugs Exemestane (Primary) ; Celecoxib
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Dec 2005 New trial record.